We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+12.7%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$363M
AUM Growth
+$79.3M
(+28%)
Cap. Flow
+$47M
Cap. Flow
% of AUM
12.93%
Top 10 Holdings %
Top 10 Hldgs %
44.65%
Holding
564
New
419
Increased
72
Reduced
36
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.97M |
| 2 |
Apple
AAPL
|
+$6.93M |
| 3 |
Amazon
AMZN
|
+$4.54M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.29M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$2.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$3.76M |
| 2 |
Broadcom
AVGO
|
+$460K |
| 3 |
PepsiCo
PEP
|
+$158K |
| 4 |
TSMC
TSM
|
+$133K |
| 5 |
SoFi Technologies
SOFI
|
+$124K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.73% |
| 2 | Healthcare | 16.53% |
| 3 | Consumer Discretionary | 10.12% |
| 4 | Consumer Staples | 9.89% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Gilead Sciences
GILD
$162B
| $9.71K | ﹤0.01% |
+126
| New | +$10K |
|
327
Moelis & Co
MC
$4.97B
| $9.66K | ﹤0.01% |
+213
| New | +$8.5K |
|
328
Cardinal Health
CAH
$53.9B
| $9.46K | ﹤0.01% |
+100
| New | +$8.45K |
|
329
T-Mobile US
TMUS
$185B
| $9.45K | ﹤0.01% |
+68
| New | +$9.54K |
|
330
Corning
GLW
$119B
| $9.32K | ﹤0.01% |
+266
| New | +$8.74K |
|
331
Sutro Biopharma
STRO
$401M
| $9.3K | ﹤0.01% |
+200
| New | +$9.96K |
|
332
Brookfield Infrastructure
BIPC
$5.2B
| $9.21K | ﹤0.01% |
+202
| New | +$9.17K |
|
333
Timken Company
TKR
$9.56B
| $9.15K | ﹤0.01% |
+100
| New | +$7.88K |
|
334
Campbell Soup
CPB
$6.55B
| $9.14K | ﹤0.01% |
+200
| New | +$10.3K |
|
335
Werner Enterprises
WERN
$2.24B
| $8.92K | ﹤0.01% |
+202
| New | +$9.08K |
|
336
Digital Realty Trust
DLR
$69.7B
| $8.54K | ﹤0.01% |
+75
| New | +$7.42K |
|
337
CenterPoint Energy
CNP
$27.7B
| $8.37K | ﹤0.01% |
+287
| New | +$8.48K |
|
338
Vodafone
VOD
$36.3B
| $8.34K | ﹤0.01% |
+883
| New | +$9.28K |
|
339
Lamar Advertising Co
LAMR
$16.2B
| $8.34K | ﹤0.01% |
+84
| New | +$8.15K |
|
340
Franklin Resources
BEN
$17.6B
| $8.23K | ﹤0.01% |
+308
| New | +$7.96K |
|
341
Peapack-Gladstone Financial
PGC
$815M
| $8.12K | ﹤0.01% |
+300
| New | +$8.2K |
|
342
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.79B
| $8.09K | ﹤0.01% |
+150
| New | +$8.28K |
|
343
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $7.9K | ﹤0.01% |
+187
| New | +$8.1K |
|
344
iShares Russell 2000 Value ETF
IWN
$14.3B
| $7.88K | ﹤0.01% |
+56
| New | +$7.57K |
|
345
Clorox
CLX
$11.6B
| $7.63K | ﹤0.01% |
+48
| New | +$7.74K |
|
346
EOG Resources
EOG
$79.2B
| $7.59K | ﹤0.01% |
+66
| New | +$7.54K |
|
347
Health Catalyst
HCAT
$154M
| $7.5K | ﹤0.01% |
+600
| New | +$7.15K |
|
348
iShares US Financials ETF
IYF
$4.67B
| $7.46K | ﹤0.01% |
+100
| New | +$7.21K |
|
349
UnitedHealth
UNH
$376B
| $7.21K | ﹤0.01% |
+15
| New | +$7.33K |
|
350
Teradata
TDC
$2.92B
| $7.16K | ﹤0.01% |
+134
| New | +$6.04K |
|
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Fairfield, Bush & Co held 564 positions worth $363M, up 28% from $284M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Fairfield, Bush & Co deployed $47M of net new capital in Q2 2023, opening 419 new positions and adding to 72 existing holdings. Its largest new stake was Meta Platforms (Facebook): 5,467 shares worth $1.57M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Novo Nordisk, an estimated $3.76M trimmed.
- Fairfield, Bush & Co's largest Q2 2023 buy was Meta Platforms (Facebook): 5,467 shares worth $1.57M.
- Fairfield, Bush & Co added most to NVIDIA in Q2 2023, an estimated $7.97M increase.
- Fairfield, Bush & Co's biggest Q2 2023 reduction was Novo Nordisk, cutting an estimated $3.76M.
- Fairfield, Bush & Co fully exited SoFi Technologies in Q2 2023, selling an estimated $124K.
- Fairfield, Bush & Co's ten largest holdings make up 45% of its $363M portfolio in Q2 2023.
- Fairfield, Bush & Co opened 419 new positions and closed 1 in Q2 2023.
- Fairfield, Bush & Co's portfolio value rose 28% quarter-over-quarter to $363M.
Based on Fairfield, Bush & Co's 13F filing for Q2 2023, filed 15 Aug 2023.